MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cortical myoclonus (see myoclonus)"

  • 2024 International Congress

    Intermediate Expansion of MARCHF6 causes FAME3 without Epilepsy

    C. Del Gamba, E. Bieth, S. Kaya, E. Leitão, K. Astudillo, S. Frucht, C. Depienne, G. Riboldi (New York City, USA)

    Objective: To describe the first case of Familial adult myoclonic epilepsy 3 (FAME3) due to intermediate intronic expansion of MARCHF6. Background: FAME is an autosomal…
  • 2024 International Congress

    ‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy

    SS. Polet, MMG. Bracke, MAJ. Tijssen, TJ. de Koning (Groningen, Netherlands)

    Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…
  • 2024 International Congress

    The Next Move in Movement Disorders: Differentiating between Hyperkinetic Movement Disorders using [18F] FDG PET

    J. Dalenberg, D. Peretti, L. Marapin, S. Jonker, E. Timmers, A. Vander Stouwe, M. Tijssen (Groningen, Netherlands)

    Objective: Understanding the differences in brain glucose metabolism between hyperkinetic movement disorders. Background: The Next Move in Movement Disorders (NEMO) study is a research initiative…
  • 2024 International Congress

    Deep Brain Stimulation for Post-Hypoxic Myoclonus: A Case Correlating Local Field Potentials to Clinical Outcome

    H. Kaur, T. Goble, A. Fenoy, R. Ramdhani (Great neck, USA)

    Objective: To correlate local filed potential (LFP) spectral data with clinical improvement of the Unified Myoclonus Rating Scale (UMRS) in post-hypoxic myoclonus (PHM) syndrome treated…
  • 2023 International Congress

    Tremor characteristics in patients with chronic inflammatory demyelinating polyneuropathy

    G. Pallada, SEM. Ten Holter, F. Eftimov, RMA. de Bie, JM. Dijk, AF. van Rootselaar (Amsterdam, Netherlands)

    Objective: To describe tremor characteristics in patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Background: Tremor is an underrecognized symptom of CIDP. There is limited data…
  • 2022 International Congress

    Myoclonus – encephalopathy induced by ifosfamide in a Non-Hodgkin lymphoma patient

    D. Rebolledo García (Mexico City, Mexico)

    Objective: Describe a clinical vignette about toxicity by ifosfamide in a man with follicular lymphoma (FL) that presented myoclonus and altered consciousness six hours after…
  • 2022 International Congress

    Using fMRI-based multivariate pattern analysis to differentiate between hyperkinetic movement disorders

    J. Dalenberg, C. Klaver, R. Marapin, M. de Koning-Tijssen (Groningen, Netherlands)

    Objective: We aimed to investigate differences in functional magnetic resonance imaging (fMRI) brain responses across hyperkinetic movement disorders (HMDs) during a bilateral finger-tapping task.We aimed…
  • MDS Virtual Congress 2021

    The Burst Duration in Cortical Myoclonus Patients, What is the Cut-Off?

    S. vd Veen, A. vd Stouwe, J. Elting, M. Tijssen (Groningen, Netherlands)

    Objective: The aim of this study is to identify a cut-off value for the burst duration of cortical myoclonus in a large cohort of myoclonus…
  • MDS Virtual Congress 2020

    Novel Dentato-Olivo-Luysian Atrophy in a Greek Family

    S. Alshimemeri, K. Yoshida, N. Visanji, E. Rogaeva, R. Munhoz, E. Slow, A. Lang, G. Kovacs (Toronto, ON, Canada)

    Objective: To describe a unique Greek family with a Dentatorubral-pallidoluysian atrophy (DRPLA) like clinical presentation and a distinctive neuropathological phenotype. Background: DRPLA is a cause…
  • MDS Virtual Congress 2020

    A Case of Lance Adams Syndrome with See-Saw Nystagmus

    G. Keeton, T. Ali, P. Sudhakar, Z. Guduru (Lexington, KY, USA)

    Objective: We present a case of Lance Adams syndrome (LAS) with see-saw nystagmus (SSN). LAS is a rare entity and first reported by Lance and Adams…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley